— Know what they know.
Not Investment Advice

AFFX NASDAQ

Affymetrix, Inc.
1W: -7.3% 1M: -0.1%
$14.01
Last traded 2016-03-31 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services

Cash Flow Trends

Operating Cash Flow
$37M -16.0% ▼
5Y CAGR: -5.3%
Capital Expenditures
$10M -32.5% ▼
Free Cash Flow
$26M -26.7% ▼
5Y CAGR: -11.5%
Dividends Paid
$0 +0.0% ▲
Buybacks
$89M -11.1% ▼
Net Change in Cash
$9M -61.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2011FY2012FY2013FY2014FY2015
— Operating Activities —
Net Income-$28M-$11M-$16M-$4M$10M
Depreciation & Amort.$33M$46M$54M$35M$22M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$100M-$163M$1M$25M$67M
Other Non-Cash Items-$74M$77M$6M-$27M-$78M
Operating Cash Flow$39M$4M$54M$43M$37M
— Investing Activities —
Capital Expenditures-$6M-$8M-$5M-$8M-$10M
Acquisitions (Net)$0-$308M$0$0-$14M
Investment Purchases-$86M$0$0$0-$50M
Investment Sales$33M$1M$0$0$0
Other Investing$187M$56M$21M$3M$1M
Investing Cash Flow$128M-$259M$16M-$5M-$73M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased-$202M-$26M-$57M-$80M-$89M
Dividends Paid$0$0$0$0$0
Other Financing-$486K$78M-$38M-$15M$46M
Financing Cash Flow-$486K$78M-$38M-$15M$46M
Net Change in Cash$166M-$176M$31M$23M$9M
Cash End of Period$202M$26M$57M$80M$89M
Free Cash Flow$34M-$4M$49M$36M$26M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms